Entera BioENTX
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 17 institutions reported holding Entera Bio Ltd. (ENTX) in their 13F filings, up 2 from Q2 2024. 3 opened new positions and 1 sold out. The largest holders were Knoll Capital Management, LLC ($7.4M), Schonfeld Strategic Advisors LLC ($1.2M) and Parkman Healthcare Partners LLC ($781K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Entera Bio Ltd.
- CUSIP
- M40527109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $129K |
| Exits | 1 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 86,471 shares bought and 56,492 shares sold, net +29,979 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 17 holders
| Knoll Capital Management, LLC | 3.42% | No change | 3,881,879 | $7.4M |
| Schonfeld Strategic Advisors LLC | 0.01% | Reduce -3.5% | 648,600 | $1.2M |
| Parkman Healthcare Partners LLC | 0.10% | Add +2.4% | 411,076 | $781K |
| UBS Group AG | 0.00% | Reduce -14.8% | 142,747 | $271K |
| Renaissance Technologies | 0.00% | Add +6.3% | 61,200 | $116K |
| Signature Estate & Investment Advisors LLC | 0.00% | New | 47,328 | $90K |
| Susquehanna International Group, LLP | 0.00% | Reduce -28.4% | 20,658 | $39K |
| Citadel Advisors | 0.00% | New | 20,553 | $39K |
| Geode Capital Management, LLC | 0.00% | No change | 17,597 | $33K |
| Osaic Holdings, Inc. | 0.00% | No change | 16,777 | $30K |
| PNC Financial Services Group, Inc. | 0.00% | No change | 13,000 | $25K |
| Cibc World Market Inc. | 0.00% | No change | 12,500 | $24K |
| HighTower Advisors, LLC | 0.00% | No change | 11,830 | $22K |
| NewEdge Advisors, LLC | 0.00% | No change | 9,000 | $17K |
| Bank of America Corp. | 0.00% | Add +181.0% | 8,430 | $16K |
| Group One Trading LLC | 0.00% | No change | 51 | $97 |
| JPMorgan Chase & Co. | 0.00% | New | 2 | $4 |
"% of holder's portfolio" is ENTX's weight in each manager's 13F, not the share of Entera Bio Ltd. the manager owns.